Monica M Kangussu-Marcolino Selected Research

Central Nervous System Infections (Central Nervous System Infection)

12/2019

Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica M Kangussu-Marcolino Research Topics

Disease

1	Cysts 01/2022
1	Amebic Dysentery (Amoebic Dysentery) 01/2020
1	Central Nervous System Infections (Central Nervous System Infection) 12/2019
1	Parasitic Diseases (Parasitic Disease) 01/2012

Drug/Important Bio-Agent (IBA)

2	lestaurtinibIBA 01/2022 - 12/2019
1	obatoclaxIBA 01/2020
1	ProdigiosinIBA 01/2020
1	AnisomycinIBA 01/2020
1	nithiamideIBA 01/2020
1	GDC-0084IBA 12/2019
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 12/2019
1	PanobinostatIBA 12/2019
1	Plicamycin FDA Link 12/2019
1	VaccinesIBA 01/2012